Loading...
Market
What will be Rezilient Health's valuation after the next funding round by end of 2025?
3
Rezilient Health•Danish Nagda•Govo Venture Partners•Bridge Ventures•Acorn Pacific Ventures•Jim McKelvey•Square•Mark and Robyn Jones
Resolution / Starting Odds
Less than $50M • 25%
$50M to $100M • 25%
$100M to $200M • 25%
More than $200M • 25%
Financial reports or announcements from Rezilient Health
Story
Rezilient Health, Led by Danish Nagda, Raises $10M in Series A Funding Led by Govo Venture Partners
Oct 3, 2024, 05:28 PM
Rezilient Health, co-founded by Danish Nagda, has successfully raised $10 million in a Series A funding round, led by Govo Venture Partners with participation from Bridge Ventures, Acorn Pacific Ventures, Jim McKelvey, co-founder of Square, and Mark and Robyn Jones. The funding will support Rezilient Health's mission to improve healthcare accessibility by reducing wait times, consolidating services, and lowering costs for employers and insurance providers. The company aims to revolutionize outpatient care by ensuring that doctors of every specialty are available at every location. This funding round marks Govo Venture Partners' first fund investment, highlighting their confidence in Rezilient Health's growth and potential.
View original story
Similar markets
Less than $50 million • 25%
$50 million to $100 million • 25%
$100 million to $150 million • 25%
More than $150 million • 25%
Less than $1.5 billion • 25%
$1.5 billion to $2 billion • 25%
$2 billion to $2.5 billion • 25%
More than $2.5 billion • 25%
Below $800M • 25%
$800M - $899M • 25%
$900M - $999M • 25%
$1B or more • 25%
Below $500 million • 25%
$500 million to $1 billion • 25%
$1 billion to $2 billion • 25%
Above $2 billion • 25%
Under $1 billion • 25%
$1-2 billion • 25%
$2-3 billion • 25%
Over $3 billion • 25%
Less than $500M • 25%
$500M to $700M • 25%
$700M to $900M • 25%
More than $900M • 25%
Less than $20M • 25%
$20M to $40M • 25%
$40M to $60M • 25%
More than $60M • 25%
Less than $100M • 33%
$100M to $200M • 33%
More than $200M • 33%
Less than $50 million • 25%
$50 million to $99 million • 25%
$100 million to $199 million • 25%
$200 million or more • 25%